These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 25284033)

  • 41. [Lennox-Gastaut syndrome in Spain: a descriptive retrospective epidemiological study].
    Herranz JL; Casas-Fernández C; Campistol J; Campos-Castelló J; Rufo-Campos M; Torres-Falcón A; de Rosendo J
    Rev Neurol; 2010 Jun; 50(12):711-7. PubMed ID: 20533249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcomes and adaptive behavior in adult patients with Lennox-Gastaut syndrome.
    Cerulli Irelli E; Petrungaro A; Pastorino GMG; Mazzeo A; Morano A; Casciato S; Salati E; Operto FF; Giallonardo AT; Di Gennaro G; Di Bonaventura C
    Epilepsia Open; 2024 Oct; 9(5):1881-1890. PubMed ID: 39110111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.
    Coppola G; Besag F; Cusmai R; Dulac O; Kluger G; Moavero R; Nabbout R; Nikanorova M; Pisani F; Verrotti A; von Stülpnagel C; Curatolo P
    Eur J Paediatr Neurol; 2014 Nov; 18(6):685-90. PubMed ID: 24929673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):82-90. PubMed ID: 29898974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution's experience and summary of the literature.
    Lemmon ME; Terao NN; Ng YT; Reisig W; Rubenstein JE; Kossoff EH
    Dev Med Child Neurol; 2012 May; 54(5):464-8. PubMed ID: 22443637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Budget impact analysis of antiepileptic drugs for Lennox-Gastaut syndrome.
    Skornicki M; Clements KM; O'Sullivan AK
    J Manag Care Spec Pharm; 2014 Apr; 20(4):400-6. PubMed ID: 24684645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of rufinamide in children and adults with Lennox-Gastaut syndrome: A post hoc analysis from Study 022.
    Arzimanoglou A; Pringsheim M; Kluger GJ; Genton P; Perdomo C; Malhotra M
    Epilepsy Behav; 2021 Sep; 124():108275. PubMed ID: 34509883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lennox-Gastaut syndrome: New treatments and treatments under investigation.
    Auvin S
    Rev Neurol (Paris); 2020 Jun; 176(6):444-447. PubMed ID: 32409177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: a single center study in Korea.
    Lee EH; Yum MS; Ko TS
    Clin Neurol Neurosurg; 2013 Jul; 115(7):926-9. PubMed ID: 23083943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term prognosis of patients with Lennox--Gastaut syndrome in recent decades.
    Kim HJ; Kim HD; Lee JS; Heo K; Kim DS; Kang HC
    Epilepsy Res; 2015 Feb; 110():10-9. PubMed ID: 25616450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox-Gastaut syndrome in clinical practice.
    Wirrell EC; Lagae L; Scheffer IE; Cross JH; Specchio N; Strzelczyk A
    Epilepsia Open; 2024 Oct; 9(5):1643-1657. PubMed ID: 38962968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures.
    Eschbach K; Moss A; Joshi C; Angione K; Smith G; Dempsey A; Juarez-Colunga E; Demarest ST
    Epilepsy Res; 2018 Nov; 147():95-101. PubMed ID: 30286391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of Lennox-Gastaut syndrome.
    Hancock EC; Cross JH
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003277. PubMed ID: 23450537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clobazam for patients with Lennox-Gastaut syndrome and epilepsy.
    Seif-Eddeine H; Ng YT
    Expert Rev Neurother; 2012 Apr; 12(4):385-93. PubMed ID: 22449211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case.
    Díaz Negrillo A; Martín Del Valle F; González Salaices M; Prieto Jurczynska C; Carneado Ruiz J
    Neurologia; 2011 Jun; 26(5):285-90. PubMed ID: 21353345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lennox-Gastaut syndrome: a consensus approach to differential diagnosis.
    Bourgeois BF; Douglass LM; Sankar R
    Epilepsia; 2014 Sep; 55 Suppl 4():4-9. PubMed ID: 25284032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review of electroencephalographic findings in Lennox-Gastaut syndrome.
    Nizami FM; Trivedi S; Kalita J
    Epilepsy Res; 2024 Sep; 205():107406. PubMed ID: 38976954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
    McCormack PL
    Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lennox-Gastaut syndrome in south Iran: electro-clinical manifestations.
    Asadi-Pooya AA; Sharifzade M
    Seizure; 2012 Dec; 21(10):760-3. PubMed ID: 22921514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.